Synapse - Works

Results (2442)

Export to EndNote / Excel

Systematic approach for predicting DMLC motor failure: A prognostic strategy

Meeting Abstract

Song, Y.; Chan, M.; Burman, C.
Medical Physics (2005)

Fulltext@MSK | Save

Novel ZnO nanotips: Potential nanomaterials for new generation of radiation detectors

Meeting Abstract

Song, Y.; Chan, M.; Burman, C.; Chen, H.; Saraf, G.; Zhong, J.; Lu, Y.
Medical Physics (2005)

Fulltext@MSK | Save

Role of gene expression profiling in distinguishing biologically and clinically distinct subclasses of endometrial carcinoma

Meeting Abstract

Boyd, J.
International Journal of Gynecological Cancer (2005)

Fulltext@MSK | Save

Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer: Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E, Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

Journal Article

Zelefsky, M.
Urologic Oncology: Seminars and Original Investigations (2005)

Fulltext@MSK | Save

Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI: McLaughlin PW, Narayana V, Meirovitz A, Troyer S, Roberson PL, Gonda R Jr, Sandler H, Marsh L, Lawrence T, Kessler M, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI

Journal Article

Zelefsky, M.
Urologic Oncology: Seminars and Original Investigations (2005)

Fulltext@MSK | Save

Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer: Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M 3rd, Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA

Journal Article

Zelefsky, M.
Urologic Oncology: Seminars and Original Investigations (2005)

Fulltext@MSK | Save

Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients: De Meerleer G, Vakaet L, Meersschout S, Villeirs G, Verbaeys A, Oosterlinck W, De Neve W, Department of Radiotherapy, Ghent University Hospital, Belgium

Journal Article

Zelefsky, M.
Urologic Oncology: Seminars and Original Investigations (2005)

Fulltext@MSK | Save

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity: Beckendorf V, Guerif S, Le Prise E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P, Centre Alexis Vautrin, Vandoeuvre les Nancy, Nancy, France

Journal Article

Zelefsky, M.
Urologic Oncology: Seminars and Original Investigations (2005)

Fulltext@MSK | Save

PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: Kwan W, Pickles T, Duncan G, Liu M, Agranovich A, Berthelet E, Keyes M, Kim-Sing C, Morris WJ, Paltiel C, Radiation Therapy Program, Fraser Valley Centre, British Columbia Cancer Agency, Surrey, British Columbia, Canada

Journal Article

Zelefsky, M.
Urologic Oncology: Seminars and Original Investigations (2005)

Fulltext@MSK | Save

Nanotechnology and Cancer: Introduction

Meeting Abstract

Yorke, E.
Medical Physics (2005)

Fulltext@MSK | Save